Application 065013
- Type
- ANDA
- Sponsor
- XGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOBRAMYCIN SULFATE | TOBRAMYCIN SULFATE | INJECTABLE;INJECTION | EQ 1.2GM BASE/VIAL | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 39822-0409 | Tobramycin | Tobramycin | X-GEN Pharmaceuticals, Inc. | ANDA | Current |
| 39822-0412 | Tobramycin | Tobramycin | X-GEN Pharmaceuticals, Inc. | ANDA | Current |
| 39822-0412 | Tobramycin | Tobramycin | XGen Pharmaceuticals DJB, Inc. | ANDA | Current |
| 39822-0412 | Tobramycin | Tobramycin | XGen Pharmaceuticals DJB, Inc. | ANDA | Current |
| 39822-0412 | Tobramycin | Tobramycin | XGen Pharmaceuticals DJB, Inc. | ANDA | Current |
| 39822-0412 | Tobramycin | Tobramycin | X-GEN Pharmaceuticals, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 18323 | SUPPL | 2012-07-30 |